0:01

So the next thing we tend to see on our

0:03

diagnostic service is the patient who

0:05

is following up after a benign biopsy.

0:09

And our protocol, we recognize that

0:13

different practices practice differently.

0:15

Our Hopkins protocol is to follow up with a

0:17

diagnostic evaluation in one year and then

0:20

return to screening if everything looks fine.

0:24

We usually follow up with the

0:25

modality that was used for biopsy.

0:27

So if it was an ultrasound-guided

0:29

biopsy, we'll do ultrasound for follow-up

0:32

was a mammogram-guided biopsy.

0:34

We use mammogram to follow.

0:36

And it's interesting to note that the literature

0:39

really does not advise six-month diagnostic

0:43

follow-up after benign biopsy, unless there's

0:45

a separate BI-RADS three finding for follow-up.

0:47

So sometimes we might have.

0:50

You know, two masses.

0:51

We biopsied one.

0:52

It was benign.

0:53

The other one is similar, appearing maybe

0:55

slightly smaller, and we're recommending

0:57

that for follow-up on the BI-RADS 3 pathway.

1:02

Or maybe there are multiple

1:03

similar groups of calcifications.

1:05

The most concerning one was biopsied and found

1:08

to be benign, and we're following the other.

1:10

Um, calcifications, that would be a reason

1:12

to do a six-month follow-up, but we don't

1:14

routinely do a six-month follow-up biopsy.

1:17

And there's some references here at the

1:19

bottom of the slide discussing the lack of

1:23

utility of six-month follow-up as a routine.

1:27

We also know that some practices go right

1:30

back to screening after a benign biopsy

1:32

and don't do any specific follow-up.

1:35

Um, I think that's, you know,

1:37

a little bit challenging, especially

1:38

for ultrasound-guided biopsies.

1:41

You know, if a mass is surrounded by

1:43

relatively dense tissue, we may not be able

1:45

to assess its size on a routine screening.

1:48

So we typically will do the

1:51

diagnostic evaluation one year later.

Follow up after Benign Biopsy Overview

HIDE

Prev Next

Interactive Transcript

Pro Tip: Click on a word in the transcript to jump to that point in the video

0:01

So the next thing we tend to see on our

0:03

diagnostic service is the patient who

0:05

is following up after a benign biopsy.

0:09

And our protocol, we recognize that

0:13

different practices practice differently.

0:15

Our Hopkins protocol is to follow up with a

0:17

diagnostic evaluation in one year and then

0:20

return to screening if everything looks fine.

0:24

We usually follow up with the

0:25

modality that was used for biopsy.

0:27

So if it was an ultrasound-guided

0:29

biopsy, we'll do ultrasound for follow-up

0:32

was a mammogram-guided biopsy.

0:34

We use mammogram to follow.

0:36

And it's interesting to note that the literature

0:39

really does not advise six-month diagnostic

0:43

follow-up after benign biopsy, unless there's

0:45

a separate BI-RADS three finding for follow-up.

0:47

So sometimes we might have.

0:50

You know, two masses.

0:51

We biopsied one.

0:52

It was benign.

0:53

The other one is similar, appearing maybe

0:55

slightly smaller, and we're recommending

0:57

that for follow-up on the BI-RADS 3 pathway.

1:02

Or maybe there are multiple

1:03

similar groups of calcifications.

1:05

The most concerning one was biopsied and found

1:08

to be benign, and we're following the other.

1:10

Um, calcifications, that would be a reason

1:12

to do a six-month follow-up, but we don't

1:14

routinely do a six-month follow-up biopsy.

1:17

And there's some references here at the

1:19

bottom of the slide discussing the lack of

1:23

utility of six-month follow-up as a routine.

1:27

We also know that some practices go right

1:30

back to screening after a benign biopsy

1:32

and don't do any specific follow-up.

1:35

Um, I think that's, you know,

1:37

a little bit challenging, especially

1:38

for ultrasound-guided biopsies.

1:41

You know, if a mass is surrounded by

1:43

relatively dense tissue, we may not be able

1:45

to assess its size on a routine screening.

1:48

So we typically will do the

1:51

diagnostic evaluation one year later.

Report

Faculty

Lisa Ann Mullen, MD

Assistant Professor; Breast Imaging Fellowship Director

Johns Hopkins Medicine

Lesson

Sample Lesson

Lesson

Palpable Lumps

Lesson

Breast Pain

Lesson

Nipple Discharge

Lesson

Skin Changes/Inflammation

Lesson

Recall from Screening

Lesson

Surveillance After Breast Cancer Treatment

Lesson

Follow Up Probably Benign Findings - BI-RADS 3

Lesson

Follow up Benign Biopsy

Lesson

Pregnant and Lactating Women

Lesson

Male Patients

Follow up after Benign Biopsy Overview